Basic Information
| LncRNA/CircRNA Name | MIR31HG |
| Synonyms | MIR31HG, hsa-lnc-31, LncHIFCAR |
| Region | GRCh38_9:21455642-21559669 |
| Ensemble | ENSG00000171889 |
| Refseq | NR_027054 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR etc. |
| Sample | bladder cancer tissues, cell lines (SV-HUC-1, T24, 5637, UM-UC-3, SW780) |
| Expression Pattern | down-regulated |
| Function Description | MIR31HG expression was remarkably decreased in bladder cancer tissues compared with adjacent noncancerous tissues. MIR31HG expression was also significantly down-regulated in four bladder cancer cell lines. Clinicopathologic analysis revealed that MIR31HG expression was negatively associated with TNM stage.In conclusion, as the host gene of miR-31, MIR31HG was remarkably downregulated in bladder cancer and cell lines. |
| Pubmed ID | 27434291 |
| Year | 2016 |
| Title | Decreased expression of LncRNA MIR31HG in human bladder cancer. |
External Links
| Links for MIR31HG | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |